BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11802313)

  • 1. Gene therapy for human severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Le Deist F; de Saint Basile G; Cavazzana-Calvo M
    Isr Med Assoc J; 2002 Jan; 4(1):51-4. PubMed ID: 11802313
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene therapy of severe combined immunodeficiencies.
    Fischer A; Hacein-Bey S; Cavazzana-Calvo M
    Nat Rev Immunol; 2002 Aug; 2(8):615-21. PubMed ID: 12154380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.
    Gaspar HB; Howe S; Thrasher AJ
    Gene Ther; 2003 Nov; 10(24):1999-2004. PubMed ID: 14566358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of severe combined immunodeficiencies: from mice to humans.
    Hacein-Bey S; Yates F; de Villartay JP; Fischer A; Cavazzana-Calvo M
    Neth J Med; 2002 Aug; 60(7):299-301. PubMed ID: 12430581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Setback for gene therapy: Two cases of leukemia in a French trial].
    Richter J; Relander T; Fasth A; Karlsson S
    Lakartidningen; 2003 Feb; 100(7):498-500. PubMed ID: 12640983
    [No Abstract]   [Full Text] [Related]  

  • 6. A milestone year for gene therapy goes unnoticed.
    Günzburg WH
    Curr Opin Mol Ther; 2004 Aug; 6(4):358-9. PubMed ID: 15468593
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gene therapy of severe combined immunodeficiency disease: proof of principle of efficiency and safety issues. Gene therapy, primary immunodeficiencies, retrovirus, lentivirus, genome].
    Fischer A; Hacein-Bey-Abina S; Lagresle C; Garrigue A; Cavazana-Calvo M
    Bull Acad Natl Med; 2005 May; 189(5):779-85; discussion 786-8. PubMed ID: 16433450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation: ADA-transduced hematopoietic stem cell therapy for ADA-SCID.
    Taupin P
    IDrugs; 2006 Jun; 9(6):423-30. PubMed ID: 16752313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary halt on gene therapy trials.
    FDA Consum; 2003; 37(2):6. PubMed ID: 12715756
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapy for inherited immunodeficiencies.
    Howe S; Thrasher AJ
    Curr Hematol Rep; 2003 Jul; 2(4):328-34. PubMed ID: 12901330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
    Fischer A; Le Deist F; Hacein-Bey-Abina S; André-Schmutz I; Basile Gde S; de Villartay JP; Cavazzana-Calvo M
    Immunol Rev; 2005 Feb; 203():98-109. PubMed ID: 15661024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy.
    Anderson WF
    Sci Am; 1995 Sep; 273(3):124-8. PubMed ID: 7652529
    [No Abstract]   [Full Text] [Related]  

  • 13. Hematopoietic stem cell gene therapy: dead or alive?
    Ferguson C; Larochelle A; Dunbar CE
    Trends Biotechnol; 2005 Dec; 23(12):589-97. PubMed ID: 16216357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy in recovery phase.
    Ready T
    Nat Med; 2002 May; 8(5):429-30. PubMed ID: 11984571
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy: how close to clinical reality?
    Agarwal SS
    Natl Med J India; 2009; 22(1):1-4. PubMed ID: 19761149
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene-therapy trials to restart following cancer risk review.
    Check E
    Nature; 2005 Mar; 434(7030):127. PubMed ID: 15758959
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy put on hold as third child develops cancer.
    Check E
    Nature; 2005 Feb; 433(7026):561. PubMed ID: 15703711
    [No Abstract]   [Full Text] [Related]  

  • 18. [Successful gene therapy of children with severe immunodeficiency. Research breakthrough hopefully for the treatment of other diseases, too].
    Fasth A; Mellgren K; Karlsson S; Richter J
    Lakartidningen; 2002 Jul; 99(28-29):3010-2. PubMed ID: 12170507
    [No Abstract]   [Full Text] [Related]  

  • 19. French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy.
    European Society of Gene Therapy
    J Gene Med; 2003 Jan; 5(1):82-4. PubMed ID: 12516054
    [No Abstract]   [Full Text] [Related]  

  • 20. Gene therapy.
    Heslop HE
    Cytotherapy; 2007; 9(6):519-20. PubMed ID: 17882715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.